ホーム › フォーラム一覧 › 「米国での投資」お役立ちフォーラム › CNBC「Mad Money」エピソードのまとめ › Mad Money: 2024年2月8日(木)の放送の要点
- このトピックは空です。
-
投稿者投稿
-
-
2024年2月8日 9:31 PM #17809
Jun Kurema (暮眞★潤)
キーマスター2024年2月8日(木)放送のCNBC「Mad Money w/ Jim Cramer」のサマリーです。ビデオクリップ&トランスクリプト(英文)が掲載されているCNBCサイトへのリンクも併記しています。
(1) Jim Cramer looks outside the Magnificent Seven, names other companies with shares that are popping (https://www.cnbc.com/2024/02/08/jim-cramer-names-stocks-that-are-popping-outside-the-magnificent-7.html)
- CNBC’s Jim Cramer told investors there’s money to be made in several companies besides the megacap tech stocks.
- He pointed to companies that could yield higher gains than low-risk investments like CDs.
(2) Executive Interview: CEO explains why GE Healthcare’s research and development is focused on AI (https://www.cnbc.com/2024/02/08/ceo-explains-why-ge-healthcare-is-so-focused-on-ai.html)
- GE Healthcare CEO Peter Arduini told CNBC’s Jim Cramer about developing AI products, including technology to make patient data more cohesive.
- AI can also also enhance imaging, and Arduini said customers are willing to pay up for advanced technology.
Ticker: GEHC
(3) [No Video Clip for non-Club Member] If you don’t own Arm yet, wait for the stock to pull back when the lockup expires, says Jim Cramer (https://www.cnbc.com/video/2024/02/08/if-you-dont-own-arm-yet-wait-for-the-stock-to-pull-back-when-the-lockup-expires-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer digs into the recent jump in Arm stock and how to play it from here.
Ticker: ARM
(4) [No Video Clip for non-Club Member] Executive Interview: Vertex Pharma CEO Kewalramani sits down with Jim Cramer (https://www.cnbc.com/video/2024/02/08/vertex-pharma-ceo-kewalramani-sits-down-with-jim-cramer.html)
Vertex Pharma President and CEO Dr. Reshma Kewalramani joins ‘Mad Money’ host Jim Cramer to talk sickle cell gene therapy, cystic fibrosis treatments and more.
Ticker: VRTX
(5) Cramer’s Lightning Round: AbbVie is ‘a very good company’ (https://www.cnbc.com/2024/02/08/cramers-lightning-round-abbvie-is-a-very-good-company.html)
- Oxford Lane Capital: “We don’t know if they’re any good at credit, and we don’t know what they own. I like the concept, and in that sense, I think I would look at Blackstone, because they really know how to do it.”
- MercadoLibre: “I was an original investor in Mercado Libre, and I have never once abandoned it. Those people are incredibly smart.”
- Freeport-McMoRan: “I think it could go up a couple of points, once the Chinese start manipulating their market higher, but that’s all you’re going to get from them. We have to go higher quality.”
- AbbVie: ”…It’s a very good company.”
Ticker: OXLC, MELI, FCX, ABBV
(6) [No Video Clip for non-Club Member] Someone needs to teach these large language models how to be better actors, says Jim Cramer (https://www.cnbc.com/video/2024/02/08/someone-needs-to-teach-these-large-language-models-how-to-be-better-actors-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer digs into Google launching Gemini chatbot.
Ticker: GOOGL
Other Stocks Discussed (calls with audience): CrowdStrike (CRWD) [54 weeks high today, wait to buy], Box (BOX) [go for more proprietary, more semiconductor]
参考: この日の放送に関するその他のサイトへのリンク
- Podcast at Spotify (音声)
- Internet Archive(1分毎のビデオ&テキスト)
****************************
前回のエピソード 次回のエピソード
-
-
投稿者投稿
- トピック「Mad Money: 2024年2月8日(木)の放送の要点」には新しい返信をつけることはできません。